Heart Failure POC And LOC Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Technology, By End Use, By Region & Competition, 2020-2030F

Description

Global Heart Failure POC And LOC Devices Market was valued at USD 110.24 million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.25% through 2030. The Global Heart Failure POC and LOC Devices Market refers to a rapidly evolving sector within the healthcare industry that focuses on the development and deployment of innovative diagnostic and monitoring devices specifically designed for heart failure patients. These devices aim to provide more efficient, cost-effective, and patient-friendly solutions for the detection, management, and treatment of heart failure. Also, certain development also leads to the growth of global heart failure LOC and POC devices market.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 110.24 Million
Market Size 2030	USD 175.97 Million
CAGR 2025-2030	8.25%
Fastest Growing Segment	Genomic testing
Largest Market	North America

Lab-on-a-Chip (LOC) technology enables rapid, high-throughput analyses, improving ease of use and reliability in disease diagnosis. Growing R&D investments in LOC-based assays, particularly for cardiovascular diseases (CVD) such as heart failure, are driving market growth. With CVD being a leading cause of mortality worldwide, the increasing need for early detection and effective management is boosting demand for LOC technology in diagnostics. The shift towards decentralized healthcare and personalized medicine is accelerating the adoption of point-of-care (POC) and LOC devices, offering faster, more accessible diagnostic solutions. Government bodies are actively supporting LOC development through funding initiatives and regulatory approvals, encouraging further innovation.

Key Market Drivers

Rising Prevalence of Heart Failure

Heart failure is a pervasive and chronic cardiovascular condition, affecting millions of people worldwide. With an aging population, sedentary lifestyles, and an increasing prevalence of risk factors such as obesity and diabetes, the incidence of heart failure is on the rise. However, this health crisis has given rise to an opportunity for innovation in healthcare. The Global Heart Failure Point of Care (POC) and Lab on a Chip (LOC) Devices Market is experiencing remarkable growth due to the escalating prevalence of heart failure.

Diabetes is a global health crisis, placing a substantial burden on developing countries like India, which is often referred to as the diabetes capital of the world. According to the ICMR-INDIAB study, over 101 million people in India are living with diabetes. The disease is linked to high morbidity and mortality, with nearly 46% of diabetic patients developing cardiovascular disease (CVD) during their lifetime. CVD is a leading cause of death among Type 2 diabetes (T2D) patients, accounting for nearly 50% of diabetes-related fatalities. Approximately 30% of diabetic patients develop heart failure, and those with both T2D and heart failure face an eightfold higher risk of death compared to individuals without heart failure. These alarming statistics highlight the urgent need for early diagnosis, intervention, and innovative treatment strategies to reduce the impact of diabetes-related cardiovascular complications.

Key Market Challenges

Accuracy and Reliability

POC and LOC devices need to be highly accurate and reliable, as errors can lead to misdiagnoses or improper management of heart failure. Ensuring consistent accuracy remains a significant challenge, especially for smaller and portable devices.

Key Market Trends

Integration of Artificial Intelligence (AI)

Artificial intelligence is increasingly being incorporated into POC and LOC devices. AI can enhance diagnostic accuracy, personalize treatment plans, and provide predictive analytics to identify potential heart failure exacerbations before they occur.

Key Market Players

Abbott Laboratories Inc
Siemens Healthineers AG
Danaher Corp
Instrumentation Laboratory Co
F Hoffmann-La Roche AG
bioMerieux S.A.
Abaxis Inc
Quidel Corp
Jant Pharmacal Corp
Trinity Biotech plc

Report Scope:

In this report, the Global Heart Failure POC And LOC Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Heart Failure POC And LOC Devices Market, By Test Type:

Proteomic testing
Metabolomic testing
Genomic testing

Heart Failure POC And LOC Devices Market, By Technology:

Microfluidics
Array-based systems
Others

Heart Failure POC And LOC Devices Market, By End Use:

Clinics
Hospitals
Home
Assisted living healthcare facilities
Laboratory
Others

Heart Failure POC And LOC Devices Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Heart Failure POC And LOC Devices Market.

Available Customizations:

Global Heart Failure POC And LOC Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Source
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Heart Failure POC And LOC Devices Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Test Type (Proteomic testing, Metabolomic testing, Genomic testing)
- 5.2.2. By Technology (Microfluidics, Array-based systems, Others)
- 5.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Rehabilitation Centers, Research Institutes, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Heart Failure POC And LOC Devices Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Technology
- 6.2.3. By End User
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Heart Failure POC And LOC Devices Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Technology
    - 6.3.1.2.3. By End User
- 6.3.2. Canada Heart Failure POC And LOC Devices Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Technology
    - 6.3.2.2.3. By End User
- 6.3.3. Mexico Heart Failure POC And LOC Devices Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Technology
    - 6.3.3.2.3. By End User

7. Europe Heart Failure POC And LOC Devices Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Technology
- 7.2.3. By End User
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Heart Failure POC And LOC Devices Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Technology
    - 7.3.1.2.3. By End User
- 7.3.2. United Kingdom Heart Failure POC And LOC Devices Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Technology
    - 7.3.2.2.3. By End User
- 7.3.3. Italy Heart Failure POC And LOC Devices Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Technology
    - 7.3.3.2.3. By End User
- 7.3.4. France Heart Failure POC And LOC Devices Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Technology
    - 7.3.4.2.3. By End User
- 7.3.5. Spain Heart Failure POC And LOC Devices Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Technology
    - 7.3.5.2.3. By End User

8. Asia-Pacific Heart Failure POC And LOC Devices Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Technology
- 8.2.3. By End User
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Heart Failure POC And LOC Devices Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Technology
    - 8.3.1.2.3. By End User
- 8.3.2. India Heart Failure POC And LOC Devices Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Technology
    - 8.3.2.2.3. By End User
- 8.3.3. Japan Heart Failure POC And LOC Devices Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Technology
    - 8.3.3.2.3. By End User
- 8.3.4. South Korea Heart Failure POC And LOC Devices Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Technology
    - 8.3.4.2.3. By End User
- 8.3.5. Australia Heart Failure POC And LOC Devices Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Technology
    - 8.3.5.2.3. By End User

9. South America Heart Failure POC And LOC Devices Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Technology
- 9.2.3. By End User
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Heart Failure POC And LOC Devices Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Technology
    - 9.3.1.2.3. By End User
- 9.3.2. Argentina Heart Failure POC And LOC Devices Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Technology
    - 9.3.2.2.3. By End User
- 9.3.3. Colombia Heart Failure POC And LOC Devices Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Technology
    - 9.3.3.2.3. By End User

10. Middle East and Africa Heart Failure POC And LOC Devices Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Technology
- 10.2.3. By End User
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Heart Failure POC And LOC Devices Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Technology
    - 10.3.1.2.3. By End User
- 10.3.2. Saudi Arabia Heart Failure POC And LOC Devices Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Technology
    - 10.3.2.2.3. By End User
- 10.3.3. UAE Heart Failure POC And LOC Devices Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Technology
    - 10.3.3.2.3. By End User
- 10.3.4. Kuwait Heart Failure POC And LOC Devices Market Outlook
  - 10.3.4.1. Market Size & Forecast
    - 10.3.4.1.1. By Value
  - 10.3.4.2. Market Share & Forecast
    - 10.3.4.2.1. By Type
    - 10.3.4.2.2. By Technology
    - 10.3.4.2.3. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global Heart Failure POC And LOC Devices Market: SWOT Analysis

14. Competitive Landscape

14.1. Abbott Laboratories Inc
- 14.1.1. Business Overview
- 14.1.2. Technology Offerings
- 14.1.3. Recent Developments
- 14.1.4. Key Personnel
- 14.1.5. SWOT Analysis
14.2. Siemens Healthineers AG
14.3. Danaher Corp
14.4. Instrumentation Laboratory Co
14.5. F Hoffmann-La Roche AG
14.6. bioMerieux S.A.
14.7. Abaxis Inc
14.8. Quidel Corp
14.9. Jant Pharmacal Corp
14.10.Trinity Biotech plc